Goldman Sachs Group Inc Oncolytics Biotech Inc Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 101,398 shares of ONCY stock, worth $78,076. This represents 0.0% of its overall portfolio holdings.
Number of Shares
101,398
Previous 84,998
19.29%
Holding current value
$78,076
Previous $73,000
28.77%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ONCY
# of Institutions
46Shares Held
1.38MCall Options Held
0Put Options Held
0-
International Assets Investment Management, LLC Orlando, FL200KShares$154,3080.02% of portfolio
-
Seeds Investor LLC New York, NY190KShares$146,2540.05% of portfolio
-
Virtu Financial LLC New York, NY98.5KShares$75,8080.0% of portfolio
-
Geode Capital Management, LLC Boston, MA66.9KShares$51,5430.0% of portfolio
-
National Bank Of Canada64.5KShares$49,6480.0% of portfolio
About ONCOLYTICS BIOTECH INC
- Ticker ONCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 57,867,400
- Market Cap $44.6M
- Description
- Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...